LABIANA HEALTH S.A.EO-10 (F:8RK) — Stock Price
LABIANA HEALTH S.A.EO-10 (F:8RK) is currently trading at €5.95 EUR, up 0.00% today. Over the past 52 weeks, shares have ranged between €3.88 and €7.70. This page tracks LABIANA HEALTH S.A.EO-10's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see 8RK operating cash flow.
LABIANA HEALTH S.A.EO-10 (8RK) Stock Price Chart — Daily History & Trading Volume
The chart below tracks LABIANA HEALTH S.A.EO-10's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
LABIANA HEALTH S.A.EO-10 Income Statement — Revenue, Profit & Earnings by Year
LABIANA HEALTH S.A.EO-10's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €75.18 Million | €66.26 Million | €58.46 Million | €57.85 Million | €56.96 Million |
| Cost of Revenue | €29.21 Million | €25.31 Million | €24.12 Million | €25.22 Million | €21.96 Million |
| Gross Profit | €45.97 Million | €40.94 Million | €34.34 Million | €32.63 Million | €35.00 Million |
| Research & Development | — | — | — | — | — |
| SG&A | — | — | — | €11.18 Million | €11.20 Million |
| Total Operating Expenses | €67.88 Million | €61.16 Million | €60.31 Million | €60.23 Million | €56.30 Million |
| Operating Income | €7.30 Million | €5.10 Million | €-1.84 Million | €-2.38 Million | €653.95K |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €5.91 Million | €4.84 Million | €3.29 Million | €2.11 Million | €2.13 Million |
| Income Before Tax | €1.20 Million | €-30.00K | €-5.27 Million | €-7.84 Million | €-2.12 Million |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €2.57 Million | €253.45K | €-4.42 Million | €-8.94 Million | €-1.78 Million |
LABIANA HEALTH S.A.EO-10 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes LABIANA HEALTH S.A.EO-10's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €57.54 Million | €52.00 Million | €59.12 Million | €60.78 Million | €68.37 Million |
| Total Current Assets | €31.53 Million | €28.70 Million | €28.98 Million | €28.76 Million | €29.41 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €1.80K | €800.25 | €13.94K | €9.10K | €11.45K |
| Net Receivables | €10.39 Million | €9.42 Million | €11.82 Million | €8.78 Million | €7.93 Million |
| Inventory | €12.03 Million | €9.98 Million | €11.11 Million | €12.71 Million | €14.92 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | €-0.01 | €-0.01 | €-0.01 | €0.00 | €1.28 Million |
| Total Liabilities | €52.79 Million | €49.43 Million | €55.72 Million | €53.87 Million | €56.84 Million |
| Total Current Liabilities | €22.66 Million | €22.16 Million | €24.70 Million | €35.06 Million | €30.45 Million |
| Long-term Debt | €29.81 Million | €26.89 Million | €29.68 Million | €16.70 Million | €23.50 Million |
| Net Debt | €30.09 Million | €27.75 Million | €37.21 Million | €33.57 Million | €39.17 Million |
| Total Stockholder Equity | €5.08 Million | €2.87 Million | €3.58 Million | €7.03 Million | €11.59 Million |
| Retained Earnings | €2.57 Million | €253.45K | €-4.42 Million | €-8.94 Million | €-1.78 Million |
LABIANA HEALTH S.A.EO-10 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how LABIANA HEALTH S.A.EO-10 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €1.70 Million | €7.19 Million | €-1.83 Million | €4.68 Million | €3.91 Million |
| Capital Expenditures | €4.44 Million | €3.05 Million | €2.85 Million | €5.45 Million | €4.77 Million |
| Free Cash Flow | €-2.74 Million | €4.15 Million | €-4.68 Million | €-774.37K | €-858.72K |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | €3.79 Million | €4.25 Million | €5.09 Million | €4.84 Million | €5.00 Million |
| Change in Cash | €-823.48K | €3.78 Million | €438.64K | €-762.32K | €1.74 Million |
LABIANA HEALTH S.A.EO-10 Earnings History — EPS Actual vs. Analyst Estimates
Track LABIANA HEALTH S.A.EO-10's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for LABIANA HEALTH S.A.EO-10.